Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Diabetes ; 71(10): 2181-2196, 2022 10 01.
Article in English | MEDLINE | ID: mdl-35796692

ABSTRACT

Patients with diabetes present a persistent inflammatory process, leading to impaired wound healing. Since nonhealing diabetic wound management shows limited results, the introduction of advanced therapies targeting and correcting the inflammatory status of macrophages in chronic wounds could be an effective therapeutic strategy to stop the sustained inflammation and to return to a healing state. In an excisional skin injury in a diet-induced diabetic murine model, we demonstrate that topical administration of low-dose aspirin (36 µg/wound/day) improves cutaneous wound healing by increasing wound closure through the promotion of the inflammation resolution program of macrophages. This treatment increased efferocytosis of wound macrophages from aspirin-treated diabetic mice compared with untreated diabetic mice. We also show that aspirin treatment of high-fat-fed mice oriented the phenotype of wound macrophages toward an anti-inflammatory and proresolutive profile characterized by a decrease of LTB4 production. The use of diabetic mice deficient for 5-LOX or 12/15-LOX demonstrated that these two enzymes of acid arachidonic metabolism are essential for the beneficial effect of aspirin on wound healing. Thus, aspirin treatment modified the balance between pro- and anti-inflammatory eicosanoids by promoting the synthesis of proresolving LXA4 through 5-LOX, LTA4, 12/15-LOX signaling. In conclusion, the restoration of an anti-inflammatory and proresolutive phenotype of wound macrophages by the topical administration of low-dose aspirin represents a promising therapeutic approach in chronic wounds.


Subject(s)
Diabetes Mellitus, Experimental , Administration, Topical , Animals , Anti-Inflammatory Agents/therapeutic use , Aspirin/metabolism , Aspirin/pharmacology , Aspirin/therapeutic use , Diabetes Mellitus, Experimental/metabolism , Inflammation/drug therapy , Inflammation/metabolism , Leukotriene A4/metabolism , Leukotriene A4/pharmacology , Leukotriene B4/metabolism , Lipoxins , Macrophages/metabolism , Mice , Phenotype , Skin/metabolism , Wound Healing
2.
Cancer Immunol Res ; 7(2): 321-334, 2019 02.
Article in English | MEDLINE | ID: mdl-30610060

ABSTRACT

Macrophage-mediated cytotoxicity is controlled by surface receptor expression and activation. Despite the numerous studies documenting the role of macrophage C-type lectin receptors (CLR) in pathogen elimination, little is known about their contribution to antitumor responses. Here, we report that IL13 inhibits T-cell lymphoma and ovarian adenocarcinoma development in tumor-bearing mice through the conversion of tumor-supporting macrophages to cytotoxic effectors, characterized by a CLR signature composed of dectin-1 and mannose receptor (MR). We show that dectin-1 and MR are critical for the recognition of tumor cells through sialic acid-specific glycan structure on their surface and for the subsequent activation of macrophage tumoricidal response. Finally, we validated that IL13 antitumor effect mediated by dectin-1 and MR overexpression on macrophages can extend to various types of human tumors. Therefore, these results identify these CLRs as potential targets to promote macrophage antitumor response and represent an attractive approach to elicit tumor-associated macrophage tumoricidal properties.


Subject(s)
Interleukin-13/genetics , Lectins, C-Type/genetics , Macrophages/immunology , Macrophages/metabolism , Mannose-Binding Lectins/genetics , Neoplasms/etiology , Neoplasms/metabolism , Receptors, Cell Surface/genetics , Animals , Arginase/metabolism , Cell Line, Tumor , Gene Expression , Humans , Interleukin-13/metabolism , Lectins, C-Type/metabolism , Mannose Receptor , Mannose-Binding Lectins/metabolism , Mice , Mice, Knockout , N-Acetylneuraminic Acid/metabolism , Necrosis/genetics , Necrosis/immunology , Neoplasms/mortality , Neoplasms/pathology , Prognosis , Reactive Oxygen Species/metabolism , Receptors, Cell Surface/metabolism , Signal Transduction , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
3.
Nat Commun ; 6: 6801, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25873311

ABSTRACT

Liver receptor homologue-1 (LRH-1) is a nuclear receptor involved in the repression of inflammatory processes in the hepatointestinal tract. Here we report that LRH-1 is expressed in macrophages and induced by the Th2 cytokine IL-13 via a mechanism involving STAT6. We show that loss-of-function of LRH-1 in macrophages impedes IL-13-induced macrophage polarization due to impaired generation of 15-HETE PPARγ ligands. The incapacity to generate 15-HETE metabolites is at least partially caused by the compromised regulation of CYP1A1 and CYP1B1. Mice with LRH-1-deficient macrophages are, furthermore, highly susceptible to gastrointestinal and systemic Candida albicans infection. Altogether, these results identify LRH-1 as a critical component of the anti-inflammatory and fungicidal response of alternatively activated macrophages that acts upstream from the IL-13-induced 15-HETE/PPARγ axis.


Subject(s)
Candidiasis/immunology , Gastroenteritis/immunology , Interleukin-13/immunology , Macrophages/immunology , PPAR gamma/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Animals , Blotting, Western , Candida albicans , Chromatin Immunoprecipitation , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/immunology , Cytochrome P-450 CYP1B1/genetics , Cytochrome P-450 CYP1B1/immunology , Cytokines/immunology , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Hydroxyeicosatetraenoic Acids/immunology , Macrophages, Peritoneal/immunology , Mice , PPAR gamma/immunology , Phagocytosis/genetics , Phagocytosis/immunology , Phenotype , Real-Time Polymerase Chain Reaction , Receptors, Cytoplasmic and Nuclear/immunology , Reverse Transcriptase Polymerase Chain Reaction , STAT6 Transcription Factor/metabolism
4.
Immunity ; 38(5): 1038-49, 2013 May 23.
Article in English | MEDLINE | ID: mdl-23684988

ABSTRACT

Macrophages act as the primary effector cells during Leishmania infection through production of reactive oxygen species (ROS) and interleukin-1ß (IL-1ß). However, how macrophage-killing mechanisms are activated during Leishmania-macrophage interactions is poorly understood. Here, we report that the macrophage response against Leishmania infantum in vivo is characterized by an M2b-like phenotype and C-type lectin receptors (CLRs) signature composed of Dectin-1, mannose receptor (MR), and the DC-SIGN homolog SIGNR3 expression. Dectin-1 and MR were crucial for the microbicidal response as indicated by the fact that they activated Syk-p47phox and arachidonic acid (AA)-NADPH oxidase signaling pathways, respectively, needed for ROS production and also triggered Syk-coupled signaling for caspase-1-induced IL-1ß secretion. In contrast, SIGNR3 has divergent functions during Leishmania infantum pathogenesis; this CLR favored parasite resilience through inhibition of the LTB4-IL-1ß axis. These pathways also operated during infection of primary human macrophages. Therefore, our study promotes CLRs as potential targets for treatment, diagnosis, and prevention of visceral leishmaniasis.


Subject(s)
Antigens, CD/metabolism , Lectins, C-Type/metabolism , Leishmania infantum/immunology , Macrophages/immunology , Mannose-Binding Lectins/metabolism , Receptors, Cell Surface/metabolism , Animals , Arachidonic Acid/metabolism , Caspase 1/metabolism , Cells, Cultured , Humans , Interleukin-1beta/antagonists & inhibitors , Interleukin-1beta/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Lectins, C-Type/immunology , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/parasitology , Leukotriene B4/antagonists & inhibitors , Mannose Receptor , Mice , Mice, Inbred C57BL , Mice, Knockout , NADPH Oxidases/metabolism , Protein-Tyrosine Kinases/metabolism , RNA Interference , RNA, Small Interfering , Reactive Oxygen Species/metabolism , Signal Transduction , Syk Kinase
5.
Nanomedicine ; 8(6): 987-95, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22100755

ABSTRACT

Because of their outstanding physical properties, carbon nanotubes (CNTs) are promising new materials in the field of nanotechnology. It is therefore imperative to assess their adverse effects on human health. Monocytes/macrophages that recognize and eliminate the inert particles constitute the main target of CNTs. In this article, we report our finding that double-walled CNTs (DWCNTs) synergize with Toll-like receptor agonists to enhance IL-1ß release in human monocytes. We show that DWCNTs-induced IL-1ß secretion is exclusively linked to caspase-1 and to Nlrp3 inflammasome activation in human monocytes. We also establish that this activation requires DWCNTs phagocytosis and potassium efflux, but not reactive oxygen specied (ROS) generation. Moreover, inhibition of lysosomal acidification or cathepsin-B activation reduces DWCNT-induced IL-1ß secretion, suggesting that Nlrp3 inflammasome activation occurs via lysosomal destabilization. Thus, DWCNTs present a health hazard due to their capacity to activate Nlrp3 inflammasome, recalling the inflammation caused by asbestos and hence demonstrating that they should be used with caution.


Subject(s)
Inflammasomes/immunology , Inflammation Mediators/immunology , Interleukin-1beta/immunology , Monocytes/drug effects , Monocytes/immunology , Nanotubes, Carbon , Cells, Cultured , Humans , Materials Testing
6.
PLoS Pathog ; 7(9): e1002254, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21949655

ABSTRACT

CD36 is the major receptor mediating nonopsonic phagocytosis of Plasmodium falciparum-parasitized erythrocytes by macrophages. Its expression on macrophages is mainly controlled by the nuclear receptor PPARγ. Here, we demonstrate that inflammatory processes negatively regulate CD36 expression on human and murine macrophages, and hence decrease Plasmodium clearance directly favoring the worsening of malaria infection. This CD36 downregulation in inflammatory conditions is associated with a failure in the expression and activation of PPARγ. Interestingly, using siRNA mediating knock down of Nrf2 in macrophages or Nrf2- and PPARγ-deficient macrophages, we establish that in inflammatory conditions, the Nrf2 transcription factor controls CD36 expression independently of PPARγ. In these conditions, Nrf2 activators, but not PPARγ ligands, enhance CD36 expression and CD36-mediated Plasmodium phagocytosis. These results were confirmed in human macrophages and in vivo where only Nrf2 activators improve the outcome of severe malaria. Collectively, this report highlights that the Nrf2 transcription factor could be an alternative target to PPARγ in the control of severe malaria through parasite clearance.


Subject(s)
CD36 Antigens/biosynthesis , Macrophages/immunology , Malaria, Falciparum/immunology , NF-E2-Related Factor 2/metabolism , Phagocytosis , Plasmodium falciparum/immunology , Animals , Down-Regulation , Erythrocytes/parasitology , Female , Humans , Macrophages/metabolism , Macrophages/parasitology , Malaria, Falciparum/parasitology , Mice , Mice, Inbred C57BL , Mice, Transgenic , NF-E2-Related Factor 2/genetics , PPAR gamma/genetics , PPAR gamma/metabolism , Plasmodium falciparum/metabolism
7.
Toxicol Appl Pharmacol ; 256(1): 35-43, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-21807015

ABSTRACT

For the effective induction of a hapten-specific T cell immune response toward contact sensitizers, in addition to covalent-modification of skin proteins, the redox and inflammatory statuses of activated dendritic cells are crucial. The aim of this study was to better understand how sensitizers modulate an inflammatory response through cytokines production and COX metabolism cascade. To address this purpose, we used the human monocytic-like U-937 cell line differentiated by phorbol myristate acetate (PMA) and investigated the effect of 6 contact sensitizers (DNCB, PPD, hydroquinone, propyl gallate, cinnamaldehyde and eugenol) and 3 non sensitizers (lactic acid, glycerol and tween 20) on the production of pro-inflammatory cytokines (IL-1ß and TNF-α) and on the arachidonic acid metabolic profile after bacterial lipopolysaccharide (LPS) stimulation. Our results showed that among the tested molecules, all sensitizers specifically prevent the production of PMA/LPS-induced COX-2 metabolites (PGE(2,) TxB(2) and PGD(2)), eugenol and cinnamaldehyde inhibiting also the production of IL-1ß and TNF-α. We further demonstrated that there is no unique PGE(2) inhibition mechanism: while the release of arachidonic acid (AA) from membrane phospholipids does not appear do be a target of modulation, COX-2 expression and/or COX-2 enzymatic activity are the major steps of prostaglandin synthesis that are inhibited by sensitizers. Altogether these results add a new insight into the multiple biochemical effects described for sensitizers.


Subject(s)
Arachidonic Acid/metabolism , Cell Differentiation/drug effects , Cell Differentiation/physiology , Haptens/physiology , Lipopolysaccharides/toxicity , Monocytes/metabolism , Tetradecanoylphorbol Acetate/toxicity , Humans , Inflammation Mediators/metabolism , Inflammation Mediators/toxicity , Macrophage Activation/drug effects , Monocytes/drug effects , U937 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...